Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
暂无分享,去创建一个
Cezmi A Akdis | C. Akdis | K. Nadeau | M. Akdiş | M. Sokolowska | W. van de Veen | L. O’Mahony | M. Brüggen | Yadong Gao | Mübeccel Akdis | Liam O'Mahony | Yadong Gao | Kari Nadeau | Ahmet Kursat Azkur | Dilek Azkur | Milena Sokolowska | Willem van de Veen | Marie-Charlotte Brüggen | A. K. Azkur | D. Azkur | A. Azkur
[1] R. Brunham,et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. , 2006, The Journal of general virology.
[2] Jing Yuan,et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury , 2020, Science China Life Sciences.
[3] D. Kelvin,et al. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection , 2020, Journal of Infection.
[4] Catharine I Paules,et al. Coronavirus Infections-More Than Just the Common Cold. , 2020, JAMA.
[5] Hui Poh Goh,et al. Treatment of COVID-19: old tricks for new challenges , 2020, Critical Care.
[6] C. Akdis,et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.
[7] J. Schwarze,et al. Lung eosinophils—A novel “virus sink” that is defective in asthma? , 2019, Allergy.
[8] Daniel Brodie,et al. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.
[9] C. Ki,et al. Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients , 2016, Journal of Infection.
[10] A. Davis,et al. Management of Critically Ill Adults With COVID-19. , 2020, JAMA.
[11] Ke Ma,et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.
[12] Yan Bai,et al. Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.
[13] Fan Yang,et al. Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China , 2020, International Journal of Infectious Diseases.
[14] M. Rothenberg,et al. Eosinophil responses during COVID-19 infections and coronavirus vaccination , 2020, Journal of Allergy and Clinical Immunology.
[15] M. Shi,et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients , 2020, Emerging microbes & infections.
[16] Anavaj Sakuntabhai,et al. High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue. , 2015, The Journal of infectious diseases.
[17] Wei Liu,et al. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study , 2020, Chinese medical journal.
[18] Jizhen Ren,et al. Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis , 2020, Journal of medical virology.
[19] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[20] M. Lazanas,et al. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design , 2020, Hellenic Journal of Cardiology.
[21] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[22] Zhigang Tian,et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[23] S. Matalon,et al. Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility , 2020, Physiological reviews.
[24] K. Yuen,et al. Studies of SARS virus vaccines. , 2008, Hong Kong medical journal = Xianggang yi xue za zhi.
[25] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[26] Edward A. Dennis,et al. Eicosanoid storm in infection and inflammation , 2015, Nature Reviews Immunology.
[27] Y. Murakami,et al. Antibody responses and protection in mice immunized orally against influenza virus. , 1996, Vaccine.
[28] Ghee Chee Phua,et al. Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection. , 2020, Annals of the Academy of Medicine, Singapore.
[29] Gui Yang,et al. CARsomes inhibit airway allergic inflammation in mice by inducing antigen‐specific Th2 cell apoptosis , 2019, Allergy.
[30] L. Pérez. Acute phase protein response to viral infection and vaccination , 2019, Archives of Biochemistry and Biophysics.
[31] F. Liew,et al. Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity , 1984, European journal of immunology.
[32] Zhan-Qiu Yang,et al. The cytokine storm of severe influenza and development of immunomodulatory therapy , 2015, Cellular and Molecular Immunology.
[33] C. Akdis,et al. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. , 2009, The Journal of allergy and clinical immunology.
[34] Mayda Gursel,et al. Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic? , 2020, Allergy.
[35] Chun-Eng Liu,et al. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients , 2020, Journal of Infection.
[36] Mario Plebani,et al. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis , 2020, Clinica Chimica Acta.
[37] Rui-guang Zhang,et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] Zhiyong Ma,et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia , 2020, The Journal of infectious diseases.
[39] M. Katze,et al. Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm , 2017, mBio.
[40] J. Hindson. COVID-19: faecal–oral transmission? , 2020, Nature Reviews Gastroenterology & Hepatology.
[41] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[42] Qi Jin,et al. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] W. Cao,et al. Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia , 2020, Emerging microbes & infections.
[44] C. Ozdemir,et al. Is BCG vaccination affecting the spread and severity of COVID‐19? , 2020, Allergy.
[45] O. Tsang,et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.
[46] Sharukh Lokhandwala,et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. , 2020, JAMA.
[47] Kun Wang,et al. Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[49] Yan Li,et al. The role of C5a in acute lung injury induced by highly pathogenic viral infections , 2015, Emerging Microbes & Infections.
[50] Can melatonin reduce the severity of COVID-19 pandemic? , 2020, International reviews of immunology.
[51] C. Bergmann,et al. Fine Tuning the Cytokine Storm by IFN and IL-10 Following Neurotropic Coronavirus Encephalomyelitis , 2018, Front. Immunol..
[52] H. Ulrich,et al. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement , 2020, Stem Cell Reviews and Reports.
[53] Jun Chang,et al. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus , 2019, PloS one.
[54] Hualiang Jiang,et al. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease , 2020, Science.
[55] Kaili Wu,et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China , 2020, JAMA ophthalmology.
[56] W. Xu,et al. Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion , 2020, Cellular & Molecular Immunology.
[57] A. Bertoletti,et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection , 2016, Vaccine.
[58] Xin Li,et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.
[59] Hui Du,et al. Eleven faces of coronavirus disease 2019 , 2020, Allergy.
[60] W. Zhou,et al. [Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19]. , 2020, Zhonghua nei ke za zhi.
[61] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[62] M. Akdiş,et al. Tolerance mechanisms of AIT. , 2019, Allergy.
[63] M. Hoelscher,et al. Lymphocytosis and Lymphopenia Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 17,229 Diseased German Travelers Returning from the Tropics and Subtropics. , 2016, The American journal of tropical medicine and hygiene.
[64] Kari Stefansson,et al. Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.
[65] P. González,et al. Contribution of Resident Memory CD8+ T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design , 2019, Pathogens.
[66] L. Poon,et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .
[67] R. Lucas,et al. The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches. , 2015, Austin journal of vascular medicine.
[68] D. Swerdlow,et al. Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014 , 2016, The American Journal of Pathology.
[69] Haibo Xu,et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.
[70] Colin Renfrew,et al. Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.
[71] Y. Yazdanpanah,et al. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.
[72] Arturo Casadevall,et al. The convalescent sera option for containing COVID-19. , 2020, The Journal of clinical investigation.
[73] R. Scheuermann,et al. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.
[74] Taojiao Wang,et al. Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. , 2020, The Journal of clinical investigation.
[75] Yong-tang Zheng,et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[76] Cassandra White,et al. Global Leprosy Status in 2020: Still Losing Touch. , 2020, Annals of the Academy of Medicine, Singapore.
[77] J. Chan,et al. From SARS coronavirus to novel animal and human coronaviruses. , 2013, Journal of thoracic disease.
[78] S. Perlman,et al. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.
[79] C. Akdis,et al. Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells , 2017, Immunological reviews.
[80] G. Rimmelzwaan,et al. Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[81] Dong-Yan Jin,et al. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses , 2020, Emerging microbes & infections.
[82] Baoying Huang,et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2 , 2020, Science.
[83] Chong-Jen Yu,et al. Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients , 2004, Emerging infectious diseases.
[84] A. Aderem,et al. Lipidomic Profiling of Influenza Infection Identifies Mediators that Induce and Resolve Inflammation , 2013, Cell.
[85] Lei Dong,et al. Kidney disease is associated with in-hospital death of patients with COVID-19 , 2020, Kidney International.
[86] M. Hoelscher,et al. Elevated Values of C-Reactive Protein Induced by Imported Infectious Diseases: A Controlled Cross-Sectional Study of 11,079 Diseased German Travelers Returning from the Tropics and Subtropics. , 2016, The American journal of tropical medicine and hygiene.
[87] L. Durant,et al. Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells , 2013, Proceedings of the National Academy of Sciences.
[88] Xuehua Peng,et al. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults , 2020, Pediatric pulmonology.
[89] Kuender D Yang,et al. Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS) , 2005, Microbes and Infection.
[90] Subha Ghosh,et al. COVID-19 Autopsies, Oklahoma, USA , 2020, American journal of clinical pathology.
[91] M. Matthay,et al. Treatment for severe acute respiratory distress syndrome from COVID-19 , 2020, The Lancet Respiratory Medicine.
[92] Lei Tu,et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study , 2020, American journal of respiratory and critical care medicine.
[93] Dong-Yan Jin,et al. Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3·TANK·TBK1/IKKϵ Complex* , 2009, The Journal of Biological Chemistry.
[94] Pengfei Sun,et al. Response to: Sore throat in COVID‐19: comment on “Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis” , 2020, Journal of medical virology.
[95] A. K. Azkur,et al. Schmallenberg virus induces apoptosis in Vero cell line via extrinsic and intrinsic pathways in a time and dose dependent manner , 2018, The Journal of veterinary medical science.
[96] Chuan Qin,et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[97] B. Hanley,et al. Autopsy in suspected COVID-19 cases , 2020, Journal of Clinical Pathology.
[98] C. K. Edwards,et al. The Biological Function and Clinical Utilization of CD147 in Human Diseases: A Review of the Current Scientific Literature , 2014, International journal of molecular sciences.
[99] Jing Yuan,et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. , 2020, JAMA.
[100] M. Tay,et al. The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.
[101] Xiao Chen,et al. Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with coronavirus disease‐19 , 2020, Journal of medical virology.
[102] A. Moreno,et al. Characteristics of Ocular Findings of Patients with Coronavirus Disease , 2020, International Journal of Advanced Engineering Research and Science.
[103] Y. Xiong,et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing , 2020, Journal of medical virology.
[104] G. Quinnan,,et al. Secretory immunoglobulin A antibody response is conserved in aged mice following oral immunization with influenza virus vaccine. , 1989, The Journal of general virology.
[105] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[106] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[107] Hong Zhou,et al. Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response , 2012, Microbes and Infection.
[108] C. Bachert,et al. Stability of regulatory T cells in T helper 2–biased allergic airway diseases , 2020, Allergy.
[109] Silke Stertz,et al. The intracellular sites of early replication and budding of SARS-coronavirus , 2007, Virology.
[110] Gianpaolo Ronconi,et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. , 2020 .
[111] Zhi-sheng Liu,et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study , 2020, World Journal of Pediatrics.
[112] W. Tang,et al. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. , 2020, European review for medical and pharmacological sciences.
[113] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[114] Syed Faraz Ahmed,et al. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies , 2020, Viruses.
[115] P. Wright,et al. Role of IgA versus IgG in the Control of Influenza Viral Infection in the Murine Respiratory Tract1 , 2004, The Journal of Immunology.
[116] F. Swirski,et al. Cytokine storm and sepsis disease pathogenesis , 2017, Seminars in Immunopathology.
[117] G. Lippi,et al. Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring , 2020, Seminars in Thrombosis and Hemostasis.
[118] Xiuyong Li,et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 , 2020, Journal of medical virology.
[119] R. Liu,et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection , 2020, Clinical chemistry and laboratory medicine.
[120] S. Varga,et al. The CD8 T Cell Response to Respiratory Virus Infections , 2018, Front. Immunol..
[121] T. Nagamine,et al. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. , 1990, Vaccine.
[122] Eun-Ha Kim,et al. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets , 2020, Cell Host & Microbe.
[123] Rachel E. Owen,et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. , 2009, The Journal of clinical investigation.
[124] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[125] D. Janz,et al. Cell-free hemoglobin: a novel mediator of acute lung injury. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[126] Qiu Zhao,et al. Liver impairment in COVID‐19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[127] R. König,et al. SARS‐CoV‐2 immunogenicity at the crossroads , 2020, Allergy.
[128] T. Palaga,et al. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. , 2020, Asian Pacific journal of allergy and immunology.
[129] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[130] B. Rouse,et al. CD4+CD25+ Regulatory T Cells Control the Severity of Viral Immunoinflammatory Lesions1 , 2004, The Journal of Immunology.
[131] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[132] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[133] M. Wujtewicz,et al. COVID-19 – what should anaethesiologists and intensivists know about it? , 2020, Anaesthesiology intensive therapy.
[134] M. Wadhwa,et al. Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release , 2013, British journal of clinical pharmacology.
[135] Jun Yuan,et al. Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.
[136] Yan Liu,et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.
[137] M. Akdiş,et al. Tolerance mechanisms of allergen immunotherapy , 2020 .
[138] Jing Chen,et al. Identification of Kidney Transplant Recipients with Coronavirus Disease 2019 , 2020, European Urology.
[139] Jing Xu,et al. Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[140] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[141] Michel Theron,et al. An interferon‐γ‐related cytokine storm in SARS patients† , 2004, Journal of medical virology.
[142] K. Markstaller,et al. An inhaled tumor necrosis factor‐alpha‐derived TIP peptide improves the pulmonary function in experimental lung injury , 2013, Acta anaesthesiologica Scandinavica.
[143] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[144] A. Osterhaus,et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.